INVA

NASDAQ HEALTHCARE

Innoviva Inc

$21.05

$0.39 (+1.89%)

Live quote

52w: $17.45 – $25.15

Loading chart…

P/E Ratio5.50

P/B Ratio1.21

EV/EBITDA—

Debt/Equity—

ROE21.99%

ROIC—

Revenue Growth14.67%

Gross Margin74.80%

Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.

Own INVA? Track it here.

Create a free account to add INVA to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account